Who invested in Indalo Therapeutics?
Indalo Therapeutics's investors include Atlas Venture and Cultivation Capital.
Who invested in Indalo Therapeutics
Funding summaryUpdated 26 Oct 2026
$9.0Mraised across 1 round since 2017, from 1 source
- Latest round
- Venture, $9.0MAug 2017
- Investors
- 2
The rounds
- Aug 2017Venture$9.0M
Source recordedSEC filing: $9.0M sold, first sale Jun 2017
Founders and team
From the SEC filings it signed: 3 on the team.
- Bradford H. WilliamsonExecutive Officeri
- George H. CappsExecutive Officer, Promoteri
- Scott H. SeiwertExecutive Officeri
On the board, as filediBen H. AuspitzPeter H. BarrettRajesh H. Devraj
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Indalo Therapeutics
How much has Indalo Therapeutics raised?
Indalo Therapeutics has raised $9.0M across 1 round since 2017.
When did Indalo Therapeutics last raise?
Indalo Therapeutics's most recent round was a Venture of $9.0M in Aug 2017.
What was Indalo Therapeutics's biggest round?
Its most recent round, $9.0M in Aug 2017, is also its largest on record.
Who backed Indalo Therapeutics first?
Indalo Therapeutics's first round on record, in Aug 2017, was backed by Atlas Venture and Cultivation Capital.
What stage is Indalo Therapeutics at?
Indalo Therapeutics's latest named round is a Venture, in Aug 2017.
Companies like Indalo Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.